- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x AKG: 2-OXOGLUTARIC ACID(Non-covalent)
- 1 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 16 residues within 4Å:- Chain A: T.91, I.92, T.93, R.98, H.325, G.326, T.327, V.328, T.329, R.330, H.331, S.342, T.343, N.344, D.391
- Ligands: AKG.1
13 PLIP interactions:13 interactions with chain A- Hydrogen bonds: A:T.93, A:T.93, A:R.98, A:H.325, A:T.327, A:V.328, A:T.329, A:R.330, A:N.344, A:N.344
- Water bridges: A:G.326
- Salt bridges: A:R.330, A:H.331
- 5 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 5 residues within 4Å:- Chain A: K.81, L.119, C.313, P.314, D.315
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.315, A:D.315
GOL.4: 2 residues within 4Å:- Chain A: H.210, Q.214
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.214, A:Q.214
- Water bridges: A:S.211
GOL.14: 9 residues within 4Å:- Chain A: M.275, S.296
- Chain B: W.140, V.271, M.275, W.283, Q.293, S.296, V.297
7 PLIP interactions:5 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:V.271, B:M.275, B:Q.293, B:S.296, B:S.296
- Water bridges: A:S.296, A:S.296
GOL.15: 5 residues within 4Å:- Chain B: K.81, L.119, C.313, P.314, D.315
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.119, B:D.315
- Water bridges: B:T.318
GOL.20: 2 residues within 4Å:- Chain B: W.261, E.263
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.263
- 10 x SCN: THIOCYANATE ION(Non-functional Binders)
SCN.5: 3 residues within 4Å:- Chain A: E.126, I.145, K.219
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.219
- Water bridges: A:R.354
SCN.6: 2 residues within 4Å:- Chain A: K.259, I.260
No protein-ligand interaction detected (PLIP)SCN.7: 3 residues within 4Å:- Chain A: V.51, E.52, L.53
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:L.53
SCN.8: 3 residues within 4Å:- Chain A: D.202
- Chain B: G.191, G.192
1 PLIP interactions:1 interactions with chain A- Water bridges: A:K.203
SCN.13: 4 residues within 4Å:- Chain A: V.161
- Chain B: K.234, R.238, D.241
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.234
SCN.16: 5 residues within 4Å:- Chain B: A.360, N.364, N.365, K.366, A.369
No protein-ligand interaction detected (PLIP)SCN.17: 5 residues within 4Å:- Chain B: D.248, K.249, Q.250, K.252, S.253
1 PLIP interactions:1 interactions with chain B- Water bridges: B:S.253
SCN.18: 2 residues within 4Å:- Chain B: G.139, K.276
No protein-ligand interaction detected (PLIP)SCN.19: 5 residues within 4Å:- Chain A: I.231
- Chain B: Q.154, Y.155, R.156, A.157
No protein-ligand interaction detected (PLIP)SCN.21: 4 residues within 4Å:- Chain A: P.163, P.165
- Chain B: Y.172, P.174
No protein-ligand interaction detected (PLIP)- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
CA.10: 3 residues within 4Å:- Chain A: D.291
- Chain B: D.268
- Ligands: AKG.1
5 PLIP interactions:1 interactions with chain B, 1 interactions with chain A, 3 Ligand-Water interactions- Metal complexes: B:D.268, A:D.291, H2O.2, H2O.4, H2O.5
CA.11: 4 residues within 4Å:- Chain A: D.268
- Chain B: D.291, D.295
- Ligands: EE1.12
5 PLIP interactions:1 interactions with chain A, 1 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: A:D.268, B:D.291, H2O.12, H2O.18, H2O.19
- 1 x EE1: (3~{S})-3-[(4~{S})-3-aminocarbonyl-1-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]-4~{H}-pyridin-4-yl]-2-oxidanylidene-pentanedioic acid(Non-covalent)
EE1.12: 20 residues within 4Å:- Chain A: K.228, D.268
- Chain B: T.91, I.92, T.93, R.98, S.110, N.112, D.291, H.325, G.326, T.327, V.328, T.329, R.330, H.331, S.342, T.343, N.344
- Ligands: CA.11
21 PLIP interactions:19 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:T.93, B:T.93, B:R.98, B:R.98, B:S.110, B:N.112, B:T.327, B:V.328, B:T.329, B:N.344, B:N.344
- Water bridges: B:G.113, B:G.326, B:T.329, B:T.329, B:H.331, B:H.331, A:D.269
- Salt bridges: B:R.330, B:H.331, A:K.228
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mealka, M. et al., Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms. Nat Commun (2024)
- Release Date
- 2024-04-24
- Peptides
- Isocitrate dehydrogenase [NADP] cytoplasmic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x AKG: 2-OXOGLUTARIC ACID(Non-covalent)
- 1 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 5 x GOL: GLYCEROL(Non-functional Binders)
- 10 x SCN: THIOCYANATE ION(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
- 1 x EE1: (3~{S})-3-[(4~{S})-3-aminocarbonyl-1-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]-4~{H}-pyridin-4-yl]-2-oxidanylidene-pentanedioic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mealka, M. et al., Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms. Nat Commun (2024)
- Release Date
- 2024-04-24
- Peptides
- Isocitrate dehydrogenase [NADP] cytoplasmic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B